News

[13] Since this 2004 study, aromatase inhibitor use and any effect on cognition remain under consideration. A 2009 ASCO Breast Cancer Symposium review of five studies evaluated the majority of ...
Treatment with an aromatase inhibitor, either alone or in combination with growth hormone (GH), slowed bone advancement and enhanced adult height in mid-pubertal boys with a short predicted adult ...
The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...
A new drug that reduces the risk of breast cancer recurrence has been approved in England. According to an analysis by the International Agency for Research on Cancer (IARC), worldwide one in ...
Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for ...
There are several different types of anti estrogen supplements available, including aromatase inhibitors, selective estrogen receptor modulators (SERMs), and estrogen blockers. Each of these ...
Panelists discuss how the EMERALD trial demonstrated elacestrant's efficacy in ESR1-mutated tumors, particularly in patients who had received CDK4/6 inhibitors for at least 12 months. This led to its ...
Considering taking supplements to treat aromatase inhibitor induced arthralgia? Below is a list of common natural remedies used to treat or reduce the symptoms of aromatase inhibitor induced ...
A new twice-daily pill has been approved for NHS use, offering a significant reduction in the risk of certain breast cancers recurring.